CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 03:00PM GMT
Release Date Price: R$29.78
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

First off in here is CVS Health Corporation, Larry Merlo, President and CEO; Eva Boratto, EVP and CFO. As all of you know, CVS Health is a leading player in retail pharmacy, leading player in pharmacy benefit management and with the acquisition last year of Aetna, a leading player in health benefits. So we're excited to hear from them. I think Larry is going to make a few opening comments, and then we'll get into a fireside chat Q&A.

And what I would suggest is if anybody in the audience would like to ask a question, probably the simplest way is just to go ahead and e-mail me at [email protected], and I can take a look at that. We've got plenty of questions in the interim.

So let me pass it on to Larry.

Larry J. Merlo
CVS Health Corporation - President, CEO & Director

All right. Thanks, A.J. It's great to be here. And actually, before we begin, our attorneys have asked me to remind everyone that statements we make today may be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot